The present invention relates to plasma-derived immunoglobulin for use in the treatment of immune reconstitution inflammatory syndrome (IRIS). Moreover, the present invention relates to a kit of parts for the treatment of IRIS comprising (a) plasma-derived immunoglobulin (b) instructions for use to administer plasma-derived immunoglobulin in the treatment of IRIS.